MedPath

A randomized, double-blind, controlled study of KIB-PCI in Japanese healthy adult volunteers

Phase 3
Conditions
Prophylaxis of new type of influenza virus infection
Registration Number
JPRN-jRCT2080221923
Lead Sponsor
DAIICHISANKYO Co.,Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
800
Inclusion Criteria

1) Japanese healthy adult volunteers

Exclusion Criteria

1) Subjects with a history of influenza A (H5N1) virus infection
2) Subjects who have received influenza A (H5N1) vaccine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath